Using anti-CD20 to confirm the identity of not otherwise specified B-cell lymphomas (BCL), we scored the expression of CD21 as negative (−), low (1+), or high (2+ or higher). The gene discussed is CR2; the disease is B-cell non-Hodgkin lymphoma.